Chin J Schisto Control ›› 2014, Vol. 26 ›› Issue (2): 224-.

Previous Articles     Next Articles

Clinical efficacy of sodium tanshinone IIA sulfonate in treatment of advanced schistosomiasis

XUAN Ai-lin1 | YOU Lu2 |JIANG Wei-Dong3   

  1. 1 Dongtai No.2 People’ s Hospital|Dongtai 224200|Jiangsu Province|China;2 Jiangsu Institute of Parasitic Diseases|China;3 Touzao Township Hospital| Dongtai City|Jiangsu Province|China
  • Online:2014-04-28 Published:2014-04-28

丹参酮IIA磺酸钠治疗晚期血吸虫病效果

宣爱林1|尤璐2|蒋卫东3   

  1. 1江苏省东台市第二人民医院 (东台 224200); 2江苏省 血吸虫病防治研究所; 3江苏省东台市头灶中心卫生院

Abstract: Objective To evaluate the clinical efficacy of sodium tanshinone IIA sulfonate(STS)in the treatment of ad? vanced schistosomiasis. Methods Fifty cases with advanced schistosomiasis admitted to the Touzao Township Hospital of Dong? tai City during the period from November 2012 to November 2013 were treated with STS for 10 days,and the internal diameter of the portal vein,levels of ALT,AST,γ?GT,PIIIP,CIV,HA and LN were measured and compared before and after the adminis? tration of STS. Results The mean levels of all serological parameters except HA were within the normal range before STS treat? ment,while the highest positive rate was detected in γ?GT(26.0%)and HA(54.0%) . Following the STS treatment,the mean lev? els of all parameters and the positive rates reduced,with the greatest reduction observed in γ?GT(36.7%)and HA(37.8%);how? ever,the mean HA level was still higher than the normal range. The mean internal diameter of the portal vein reduced from(10.5± 1.7)mm before the STS treatment to(9.8±1.3)mm after the STS administration,with a significant diffrtence(P < 0.05) . Conclu? sion STS appears effective in the treatment of advanced schistosomiasis.

Key words: Sodium tanshinone IIA sulfonate (STS); Advanced schistosomiasis;Clinical efficacy

摘要: 目的 目的 观察丹参酮IIA磺酸钠注射液 (STS) 治疗晚期血吸虫病 (晚血) 临床效果。 方法 方法 选择2012?011-2013?11 入住东台市头灶中心卫生院的晚血患者50例, 予以STS治疗10 d, 治疗前、 后进行门静脉内径、 丙氨酸氨基转移酶、 天冬氨 酸氨基转移酶、 γ?谷氨酰转肽酶 (γ?GT)、 Ⅲ型前胶原肽、 Ⅳ型胶原、 层黏蛋白、 透明质酸 (HA) 检测。结果 结果 治疗前血清学检 测指标的均值除HA高于正常外, 余均正常; 指标异常患者数最高分别为γ?GT (26.0%) 及HA (54.0%)。治疗后各项指标均 值和指标异常患者数均有所下降, 但HA的均值仍高于正常。门静脉内径由治前的 (10.5±1.7) mm降至治后的 (9.8±1.3) mm, 改善明显。结论 结论 STS对晚血病人的治疗具有一定的效果, 适合于基层单位使用。

关键词: 晚期血吸虫病; 丹参酮IIA磺酸钠注射液; 疗效

CLC Number: